Delivery Order SPE2DB25D3202-SPE2DB25FTAFR
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,564,248,049 milliliters of the pharmaceutical drug Medroxyprogesterone Acetate 150 mg/mL. The award has a ceiling value of $5,139.63 and a period of performance through April 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp,...
This federal contract award, valued at $2,033.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MEDROXYPROGESTERONE 150 MG/MLML, a medical product, and has an ultimate completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,207.47 firm fixed-price contract is for the provision of 4564590838 - MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC...
This federal contract award, valued at $1,493.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a medical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.90 firm fixed-price delivery order is for the procurement of MEDROXYPROGESTERONE 150 MG/MLML, a specialty medication, with a period of performance through November 8, 2024. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $2,309.68 and was awarded on September 20, 2022, with a completion date of September 21, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,004.34, is for the delivery of medroxyprogesterone 150 mg/ml, a specialty medication. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price valued at $1,717.80. The contract is for the provision of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that maintains Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal...
This federal contract award, valued at $1,680.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order for the supply of MEDROXYPROGESTERONE 150 MG/ML, a medication, with a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,404.20 firm fixed price delivery order contract is for the provision of Medroxyprogesterone 150 mg/ml medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for delivering a...